Literature DB >> 18701878

Infection control requirements for dialysis facilities and clarification regarding guidance on parenteral medication vials.

.   

Abstract

In April 2008, the Centers for Medicare and Medicaid Services (CMS) published in the Federal Register its final rule on Conditions for Coverage for End-Stage Renal Disease (ESRD) Facilities. The rule establishes new conditions dialysis facilities must meet to be certified under the Medicare program and is intended to update CMS standards for delivery of quality care to dialysis patients. CDC's 2001 Recommendations for Preventing Transmission of Infections among Chronic Hemodialysis Patients have been incorporated by reference into the new CMS conditions for coverage. Thus, effective October 14, 2008, all ESRD facilities are expected to follow the CDC recommendations as a condition for receiving Medicare payment for outpatient dialysis services.

Entities:  

Mesh:

Year:  2008        PMID: 18701878

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  16 in total

1.  Patient-care practices associated with an increased prevalence of hepatitis C virus infection among chronic hemodialysis patients.

Authors:  Gayle Shimokura; Feng Chai; David J Weber; Gregory P Samsa; Guo-Liang Xia; Omana V Nainan; Leslie H Tobler; Michael P Busch; Miriam J Alter
Journal:  Infect Control Hosp Epidemiol       Date:  2011-05       Impact factor: 3.254

Review 2.  Immune response to hepatitis B vaccine among patients on hemodialysis.

Authors:  Gasim I Gasim; Abdelhaleem Bella; Ishag Adam
Journal:  World J Hepatol       Date:  2015-02-27

Review 3.  Hepatitis B vaccine by intradermal route in non responder patients: an update.

Authors:  Martina Filippelli; Elena Lionetti; Alessia Gennaro; Angela Lanzafame; Teresa Arrigo; Carmelo Salpietro; Mario La Rosa; Salvatore Leonardi
Journal:  World J Gastroenterol       Date:  2014-08-14       Impact factor: 5.742

4.  Blood-borne viral infections in pediatric hemodialysis.

Authors:  Shina Menon; Raj Munshi
Journal:  Pediatr Nephrol       Date:  2018-07-21       Impact factor: 3.714

5.  Molecular epidemiology of a hepatitis C virus epidemic in a haemodialysis unit: outbreak investigation and infection outcome.

Authors:  Simone Lanini; Isabella Abbate; Vincenzo Puro; Fabrizio Soscia; Franceso Albertoni; Walter Battisti; Amilacare Ruta; Maria R Capobianchi; Giuseppe Ippolito
Journal:  BMC Infect Dis       Date:  2010-08-27       Impact factor: 3.090

6.  Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN).

Authors:  Roberto Minutolo; Alessio Aghemo; Antonio Chirianni; Fabrizio Fabrizi; Loreto Gesualdo; Edoardo G Giannini; Paolo Maggi; Vincenzo Montinaro; Ernesto Paoletti; Marcello Persico; Francesco Perticone; Salvatore Petta; Massimo Puoti; Giovanni Raimondo; Maria Rendina; Anna Linda Zignego
Journal:  Infection       Date:  2018-09-25       Impact factor: 3.553

7.  Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN).

Authors:  Roberto Minutolo; Alessio Aghemo; Antonio Chirianni; Fabrizio Fabrizi; Loreto Gesualdo; Edoardo G Giannini; Paolo Maggi; Vincenzo Montinaro; Ernesto Paoletti; Marcello Persico; Francesco Perticone; Salvatore Petta; Massimo Puoti; Giovanni Raimondo; Maria Rendina; Anna Linda Zignego
Journal:  J Nephrol       Date:  2018-09-25       Impact factor: 3.902

8.  Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN).

Authors:  Roberto Minutolo; Alessio Aghemo; Antonio Chirianni; Fabrizio Fabrizi; Loreto Gesualdo; Edoardo G Giannini; Paolo Maggi; Vincenzo Montinaro; Ernesto Paoletti; Marcello Persico; Francesco Perticone; Salvatore Petta; Massimo Puoti; Giovanni Raimondo; Maria Rendina; Anna Linda Zignego
Journal:  Intern Emerg Med       Date:  2018-09-25       Impact factor: 3.397

9.  A randomized controlled trial of two schedules of hepatitis B vaccination in predialysed chronic renal failure patients.

Authors:  Farokhlagha Ahmadi; Morteza Ramezani; Effat Razeghi; Neda Ranjbarnovin; Zahra Khazaeipour
Journal:  Hepat Mon       Date:  2012-05-30       Impact factor: 0.660

10.  Risk factors for bloodstream infection in patients at a Brazilian hemodialysis center: a case-control study.

Authors:  Dayana Fram; Meiry Fernanda Pinto Okuno; Mônica Taminato; Vinicius Ponzio; Silvia Regina Manfredi; Cibele Grothe; Angélica Belasco; Ricardo Sesso; Dulce Barbosa
Journal:  BMC Infect Dis       Date:  2015-03-26       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.